Assignee
GTX INC
US28 patents
Top patents by PatentIndex Score
US8003689B2Aug 23, 2011
Metabolites of selective androgen receptor modulators and methods of use thereof
GTX INC48 citations97
US6899888B2May 31, 2005
Prevention and treatment of androgen-deprivation induced osteoporosis
GTX INC52 citations96
US9150501B2Oct 6, 2015
Solid forms of selective androgen receptor modulators
GTX INC19 citations91
US10441570B2Oct 15, 2019
Selective androgen receptor degrader (SARD) Ligands and methods of use thereof
GTX INC12 citations84
US10035763B2Jul 31, 2018
Selective androgen receptor degrader (SARD) ligands and methods of use thereof
GTX INC15 citations84
US10017471B2Jul 10, 2018
Selective androgen receptor degrader (SARD) ligands and methods of use thereof
GTX INC15 citations84
US9814698B2Nov 14, 2017
Selective androgen receptor degrader (SARD) ligands and methods of use thereof
GTX INC17 citations84
US7595402B2Sep 29, 2009
Prodrugs of selective androgen receptor modulators and methods of use thereof
GTX INC9 citations84
US10597354B2Mar 24, 2020
Selective androgen receptor degrader (SARD) ligands and methods of use thereof
GTX INC7 citations83
US10093613B2Oct 9, 2018
Selective androgen receptor degrader (SARD) ligands and methods of use thereof
GTX INC9 citations83
US9834507B2Dec 5, 2017
Selective androgen receptor degrader (SARD) ligands and methods of use thereof
GTX INC13 citations83
US9815776B2Nov 14, 2017
Selective androgen receptor degrader (SARD) ligands and methods of use thereof
GTX INC13 citations83
US9447049B2Sep 20, 2016
Compounds for treatment of cancer
GTX INC12 citations82
US10849873B2Dec 1, 2020
Non-invasive method of evaluating breast cancers for selective androgen receptor modulator (SARM) therapy
GTX INC1 citations73
US10258596B2Apr 16, 2019
Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
GTX INC4 citations73
US9969683B2May 15, 2018
Method of treating estrogen receptor (ER)-positive breast cancers with selective androgen receptor modulator (SARMS)
GTX INC3 citations73
US9744149B2Aug 29, 2017
Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
GTX INC3 citations73
US9622992B2Apr 18, 2017
Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
GTX INC3 citations73
US9604916B2Mar 28, 2017
Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
GTX INC2 citations73
US9624161B2Apr 18, 2017
Estrogen receptor ligands and methods of use thereof
GTX INC4 citations72
US10987334B2Apr 27, 2021
Method of treating ER mutant expressing breast cancers with selective androgen receptor modulators (SARMs)
GTX INC0 citations62
US10314807B2Jun 11, 2019
Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
GTX INC1 citations62
US7524866B2Apr 28, 2009
Prevention and treatment of androgen—deprivation induced osteoporosis
GTX INC3 citations62
US11090283B2Aug 17, 2021
Solid forms of selective androgen receptor modulators
GTX INC0 citations61
US9051267B2Jun 9, 2015
Estrogen receptor ligands and methods of use thereof
GTX INC2 citations60
US9981915B2May 29, 2018
Compounds for treatment of cancer
GTX INC0 citations52
US9409856B2Aug 9, 2016
Estrogen receptor ligands and methods of use thereof
GTX INC1 citations48
US9604931B2Mar 28, 2017
Nuclear receptor binding agents
GTX INC0 citations35